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Guillain-Barré Syndrome (GBS) generally 
presents with paresthesias, ascending weak-
ness, and areflexia, although dysautonomia is 
a well-known phenomenon.  Posterior Re-
versible Encephalopathy Syndrome (PRES) 
classically presents with headache, altered 
alertness, confusion, seizures and abnormali-
ties of vision; hemianopia, visual neglect, 
and cortical blindness may also occur.  There 
are a few reports that describe PRES in asso-
ciation with GBS prior to treatment, and au-
thors speculate that the dysautonomia of 
GBS leads to acute elevations in blood pres-
sure (BP) and PRES in these unusual cases.  
This conclusion stems from the high improb-
ability of both rare diseases occurring simul-
taneously purely by coincidence.  A couple 
of studies have examined the use of urinary 
catecholamines to measure dysautonomia in 
GBS, and both conclude that elevated urinary 
catecholamines correlate with clinical dysau-
tonomia in GBS.  We describe a patient with 
concurrent PRES and GBS whose urine cate-
cholamines were elevated when most symp-
tomatic and then normalized with recovery, 
which helps to support the theory that the 
dysautonomia of GBS led to the 
 
 
patient’s acute elevation in blood pressure 
and ultimately PRES. 
 
Case Report 
 
A 73-year-old normotensive male presented 
to an outside hospital with a one-day history 
of difficulty opening envelopes, turning keys 
and “numbness” in his feet.  He reported a 
sore throat a week before.  During the next 
five days his weakness progressed to include 
both proximal upper and lower extremities, 
although deep tendon reflexes remained. An 
MRI of the cervical spine was unremarkable. 
Lumbar puncture revealed no leukocytes and 
a protein of 93.  He was subsequently trans-
ferred to our hospital with suspected GBS. 
 
Upon arrival, the patient complained of visu-
al loss and headache.  His BP was 210/110.  
He was visually inattentive to his left side 
and had a left visual hemianopia.  Immediate 
head CT showed bilateral occipital hypoden-
sities consistent with PRES, which subse-
quent MRI confirmed (Figure 1).  He was 
immediately treated with intravenous labeto-
lol, and visual symptoms resolved within  
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with PRES, although most are related to 
treatment of GBS with IVIg. Many of the 
cases unrelated to IVIg are in the pediatric 
literature, but three case reports describe sim-
ultaneous GBS and PRES prior to treatment 
in adults.1-3  In all three cases, patients im-
proved with BP control and treatment with 
IVIg.  These authors suspected GBS dysauto-
nomia-induced hypertension as the etiology 
of PRES.  However, they based this conclu-
sion without additional data, on the unlikeli-
hood of both diseases coincidentally occur-
ring concurrently. 
 
Two studies have examined the use of uri-
nary catecholamines to measure dysautono-
mia in GBS.4,5  In one study,4 7 of 25 patients 
with GBS had dysautonomia, and their uri-
nary measurements revealed high values at 
the height of paralysis.  With recovery, the 
catecholamines returned to within normal 
limits.  In a second study,5 10 of 12 patients 
with GBS dysautonomia had an increase of 
urinary methoxylated metabolites.  Patients 
without clinical dysautonomia had normal 
values.  The authors concluded that elevated 
urinary catecholamines correlate with clinical 
dysautonomia in GBS and can be used as a 
biological marker.  Our patient had elevated 
urine catecholamines when most symptomat-
ic, and these values normalized with recov-
ery. These findings help support our theory 
that the dysautonomia of GBS led to PRES 
in our patient. 
Table 1: Urine Catecholamines    
24 Hour Urine Metanephrines 2nd day of admission  
μg/24 hours (NL) 
*14 days later  
μg/24 hours (NL) 
Metanephrine 484 (44-261) 200 (35 – 460) 
Normetanephrine 1030 (468-560) 958 (110-1050) 
  
NL = normal lab values 
  *outside laboratory 
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45 minutes.  Other significant exam findings 
at that time included quadraparesis and ab-
sent reflexes except for trace brachioradialis 
reflexes.  Electromyography (EMG) demon-
strated an acute mixed motor and sensory 
demyelinating polyneuropathy.  We diag-
nosed GBS and treated the patient with five 
sessions of plasmapheresis. 
 
The patient required three days of intrave-
nous labetalol and nicardipine and then was 
transitioned to oral amlodipine. He under-
went investigations to work up hypertension: 
EKG and MRI of the renal arteries were nor-
mal.   Urine catecholamines on hospital day 
two were elevated and repeat levels upon res-
olution of signs and symptoms at the rehabil-
itation hospital were normal (Table 1). 
 
Discussion 
 
Our patient initially presented with character-
istic GBS symptoms, and spinal fluid and 
EMG supported the diagnosis.  Prior to any 
treatment, including intravenous immuno-
globulin (IVIg), the patient developed PRES.  
Known precipitants are acute elevations of 
BP, renal decompensation, immunosuppres-
sants and IVIg.  We surmise that the dysauto-
nomia of GBS led to hypertension and ulti-
mately PRES in this patient. 
 
Review of the literature shows a number of 
case reports describing GBS in combination  
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However, the literature reveals cases in 
which patients develop PRES after IVIg 
treatment for GBS,6,7 although no clear 
mechanism has been described.  The three 
above-cited cases all treated these patients 
with IVIg with no reported complications.  
We treated our patient with plasmapheresis 
because of the concern of exacerbating PRES 
with IVIg. 
 
Our case adds to the growing literature of 
patients with simultaneous GBS and PRES.   
We treated the patient with plasmapheresis, 
because IVIg also poses an independent risk 
of PRES.  However, further research is nec-
essary to determine if urine catecholamines 
are a useful marker of GBS dysautonomia 
and if there are any differences in outcomes 
for patients with concurrent GBS and PRES 
treated with IVIg versus plasmapheresis. 
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Figure 1: MRI of brain, FLAIR sequence 
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